PDE-5 inhibitor donor intravenous preconditioning is superior to supplementation in standard preservation solution in experimental lung transplantation

Eur J Cardiothorac Surg. 2007 Jul;32(1):42-7. doi: 10.1016/j.ejcts.2007.03.044. Epub 2007 May 7.

Abstract

Objective: Improvement of preservation is still a major research objective in lung transplantation. The effects of phosphodiesterase-5 (PDE-5) inhibitors during procurement are still not clear. It was the aim of this study to investigate the effect of sildenafil on post-transplanted lung function in a porcine model using different application procedures.

Methods: In control group lungs were flushed with buffered low-potassium dextran (LPD) solution (I) and compared to LPD solution with supplementation of 0.15 mg/kg body weight (BW) sildenafil (II), whereas in a third group 0.15 mg/kg BW sildenafil was administered intravenously 20 min prior to LPD flushing (III). All grafts were stored for 24 h at 4-6 degrees C. Hemodynamics and blood gases were monitored until 6 h after reperfusion. Lung tissue was taken for wet/dry ratio assessment.

Results: All animals of groups I and III survived the entire observation period in contrast to four animals of group II which died within 4 h after reperfusion due to severe reperfusion injury. Group II showed a lower mean PAP and a reduced pulmonary vascular resistance (PVR) throughout the observation period, but did not reach significance due to low number of surviving animals. Group III achieved significantly improved PO2/FiO2 fraction at all timepoints and a significant reduced PVR [434+/-98 vs 594+/-184 dyn s cm(-5), II vs I; mean+/-SD, p<0.01] at 6 h. Wet/dry ratio was significantly higher in group II throughout the experiment.

Conclusions: Sildenafil allows for a better graft function after 24 h ischemia when given prior to standard flushing and preservation. This effect can be explained by a complete/homogenous preservation achieved by selective pulmonal vasodilatation. However, this effect seems to persist when sildenafil remains in the storage solution, leading to severe pulmonary edema.

MeSH terms

  • 3',5'-Cyclic-GMP Phosphodiesterases / antagonists & inhibitors*
  • Animals
  • Blood Pressure / drug effects
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Drug Evaluation, Preclinical
  • Extravascular Lung Water / drug effects
  • Graft Survival / drug effects
  • Lung Transplantation*
  • Male
  • Organ Preservation / methods
  • Phosphodiesterase Inhibitors / pharmacology*
  • Piperazines / pharmacology*
  • Pulmonary Artery / physiology
  • Pulmonary Edema / pathology
  • Pulmonary Edema / prevention & control
  • Purines / pharmacology
  • Reperfusion Injury / prevention & control
  • Sildenafil Citrate
  • Sulfones / pharmacology*
  • Swine
  • Transplantation Conditioning / methods*
  • Vascular Resistance / drug effects

Substances

  • Phosphodiesterase Inhibitors
  • Piperazines
  • Purines
  • Sulfones
  • Sildenafil Citrate
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 5